• Valemetostat (DS-3201) in Lymphoma Research

  2026-08-19

  Valemetostat, also known as DS-3201, gives lymphoma researchers a practical way to test potent EZH2 suppression across wild-type and recurrent mutant backgrounds while examining the biological rationale for EZH1/2 co-targeting. This guide connects enzyme potency with cell-based epigenetic readouts, mutation-aware dose design, and troubleshooting for reproducible lymphoma assays.

• EZ Cap™ Firefly Luciferase mRNA: Assay Design

  2026-08-18

  EZ Cap™ Firefly Luciferase mRNA can function as more than a bioluminescent endpoint: it is a practical probe of delivery, translation, cellular energy, and assay stability. This guide connects Cap1/poly(A) engineering with storage decisions and the latest trehalose-loaded LNP evidence.

• Mc-Val-Cit-PABC-PNP Workflow Guide

  2026-08-18

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker intended to support lysosome-triggered payload release in antibody-drug conjugate research. It is suitable for controlled, organic-solvent-based workflows but is insoluble in water and ethanol, not recommended for long-term solution storage, and not intended for diagnostic, clinical, or therapeutic use.

• Foretinib: From Kinase Potency to Assay Meaning

  2026-08-17

  Foretinib and GSK1363089 research often emphasizes kinase potency, but meaningful interpretation requires separating growth arrest, cell death, and motility. This guide develops an assay-centered framework for tumor cell growth inhibition, metastatic behavior, and translational model selection.

• LGK-974: Reliable PORCN Inhibition in Wnt Assays

  2026-08-17

  This scenario-driven guide explains how LGK-974 (Porcupine Inhibitor), SKU B2307, can improve interpretation and reproducibility in Wnt-dependent viability, proliferation, and cytotoxicity assays. It connects mechanism, dosing, solvent handling, controls, and vendor selection to practical laboratory decisions.

• SC 79: Akt Signaling From Stroke to Cancer

  2026-08-16

  SC 79 offers a mechanistically distinctive way to activate cytosolic Akt, linking neuroprotection research with emerging cancer ferroptosis studies and a more rigorous translational strategy.

• Genotyping Kit: From Sample to Allele Call

  2026-08-15

  The Genotyping Kit for target alleles streamlines PCR-ready DNA preparation from tissues, insects, fishes, and cells. This article connects rapid genotyping with assay decisions inspired by NR1I3–E-cadherin research in experimental colitis.

• BCECF-AM for Secretory Pathway pH Mapping

  2026-08-15

  BCECF-AM enables ratiometric intracellular pH measurement with strong relevance to live-cell studies of secretion, trafficking, and stress. This article shows how to interpret cytosolic pH changes in plant and mammalian systems without confusing a global cellular readout with organelle-specific acidification.

• GS-4997 Halts Tubulointerstitial Injury in Lupus Nephritis

  2026-08-14

  A 2024 FASEB Journal study identifies ASK1 signaling as a pharmacologically tractable driver of tubulointerstitial injury in lupus nephritis. In lupus-prone mice and LPS-stimulated renal tubular cells, GS-4997 reduced inflammation, fibrosis, renal injury, and downstream p38/JNK activation, supporting further investigation of ASK1-directed mechanisms in renal disease.

• Sulfo-NHS-LC-Biotin Protocol and QC Guide

  2026-08-14

  Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of primary amines on proteins, peptides, and intact-cell surface proteins. It is suited to downstream streptavidin capture and detection, but not to reversible labeling or intracellular biotinylation of intact cells.

• PORCN Inhibition for Sclerosteosis: Study Insights

  2026-08-13

  The 2025 Bone Research study evaluates LGK-974 as a pharmacological strategy for sclerosteosis, an ultra-rare high-bone-mass disorder caused by loss of functional sclerostin. By combining osteoblast assays, osteoclast analyses, Sost-deficient mice, microcomputed tomography, and mechanical loading, the authors show that PORCN inhibition can reduce Wnt-dependent bone formation and skeletal overgrowth without measurably suppressing osteoclast activity in the tested systems.

• Bay 11-7821: NF-κB Assay Workflows

  2026-08-13

  Bay 11-7821 (BAY 11-7082) is a practical IKK-pathway probe for connecting inflammatory signaling with apoptosis, macrophage responses, and cancer-cell phenotypes. This workflow-focused guide shows how to pair NF-κB readouts with HMGB1, exosome, viability, and mechanistic controls for more interpretable experiments.

• WM-8014 in KAT6A Senescence Workflows

  2026-08-12

  WM-8014 is a reversible, competitive KAT6A inhibitor for separating histone acetyltransferase activity from nonspecific toxicity. This guide translates its biochemical selectivity into time-gated CRISPR, senescence, cell-cycle, and cancer biology workflows with practical optimization and troubleshooting advice.

• MK-571: A Two-Axis Guide to Inflammation Assays

  2026-08-12

  MK-571 and L-660,711 provide a powerful way to separate cysteinyl leukotriene signaling from ABCC1/MRP1-mediated transport in inflammation and macrophage-protection assays. This guide translates receptor pharmacology and recent system Xc− findings into practical experimental decisions.

• SIS3 Smad3 Inhibitor: Applied Assay Workflows

  2026-08-11

  SIS3 is a selective Smad3 inhibitor for separating canonical TGF-β signaling from broader pathway effects in fibrosis and cancer models. This practical guide covers stock preparation, pathway validation, LUAD-oriented assay design, and troubleshooting for reproducible mechanistic studies.

445 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page